Table 3.
Comparison of physiological indicators between groups.
| Variable | Intervention group (n=25) | Control group (n=24) | ANCOVAa | Partial ε2 | R2 (adjusted R2) | Power | |||
|
|
Pretest, mean (SD) | Posttest, mean (SD) | Pretest, mean (SD) | Posttest, mean (SD) | F value (df=1) | P value |
|
|
|
| Creatinine (mg/dL) | 1.15 (0.34) | 1.16 (0.39) | 1.33 (0.44) | 1.51 (0.81) | 1.300 | .26 | 0.027 | 0.810 (0.801) | 0.200 |
| eGFRb (mL/min/1.73 m2) | 73.03 (25.01) | 72.47 (24.28) | 64.27 (22.72) | 56.69 (22.25) | 5.341 | .03 | 0.104 | 0.921 (0.918) | 0.619 |
| Uric acid (mg/dL) | 6.28 (1.29) | 6.28 (1.14) | 6.30 (1.63) | 6.70 (1.60) | 2.271 | .14 | 0.047 | 0.575 (0.556) | 0.314 |
| T-CHOc (mg/dL) | 181.80 (37.57) | 179.40 (35.20) | 174.42 (43.83) | 169.21 (39.54) | 0.553 | .46 | 0.012 | 0.685 (0.672) | 0.113 |
| TGd (mg/dL) | 170.28 (77.99) | 160.20 (85.29) | 257.37 (273.39) | 272.87 (380.67) | 0.225 | .64 | 0.005 | 0.540 (0.520) | 0.075 |
| LDL-Ce (mg/dL) | 108.24 (29.78) | 105.84 (27.86) | 95.62 (38.25) | 92.29 (31.90) | 0.932 | .34 | 0.020 | 0.840 (0.833) | 0.157 |
| GluACf (mg/dL) | 111.04 (39.12) | 112.76 (41.91) | 118.25 (39.13) | 116.25 (28.74) | 0.007 | .93 | 0.000 | 0.396 (0.370) | 0.051 |
aANCOVA: analysis of covariance.
beGFR: estimated glomerular filtration rate.
cT-CHO: total cholesterol.
dTG: triglyceride.
eLDL-C: low-density lipoprotein cholesterol.
fGluAC: glucose ante cibum.